Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Prevalence of pulmonary hypertension in pulmonary sarcoidosis; the first large European prospective study.

Huitema MP, Bakker ALM, Mager JJ, Rensing BJWM, Smits F, Snijder RJ, Grutters JC, Post MC.

Eur Respir J. 2019 Jul 18. pii: 1900897. doi: 10.1183/13993003.00897-2019. [Epub ahead of print] No abstract available.

PMID:
31320453
2.

Octreotide for gastrointestinal bleeding in hereditary hemorrhagic telangiectasia: A prospective case series.

Kroon S, Snijder RJ, Mager JJ, Post MC, Tenthof van Noorden J, van Geenen EJM, Drenth JPH, Grooteman KV.

Am J Hematol. 2019 Jun 28. doi: 10.1002/ajh.25563. [Epub ahead of print] No abstract available.

PMID:
31251413
3.

Long-term clinical value and outcome of riociguat in chronic thromboembolic pulmonary hypertension.

van Thor MCJ, Ten Klooster L, Snijder RJ, Post MC, Mager JJ.

Int J Cardiol Heart Vasc. 2019 Feb 28;22:163-168. doi: 10.1016/j.ijcha.2019.02.004. eCollection 2019 Mar.

4.

Decreased Expression of Vascular Endothelial Growth Factor Receptor 1 Contributes to the Pathogenesis of Hereditary Hemorrhagic Telangiectasia Type 2.

Thalgott JH, Dos-Santos-Luis D, Hosman AE, Martin S, Lamandé N, Bracquart D, Srun S, Galaris G, de Boer HC, Tual-Chalot S, Kroon S, Arthur HM, Cao Y, Snijder RJ, Disch F, Mager JJ, Rabelink TJ, Mummery CL, Raymond K, Lebrin F.

Circulation. 2018 Dec 4;138(23):2698-2712. doi: 10.1161/CIRCULATIONAHA.117.033062.

PMID:
30571259
5.

Percutaneous patent foramen ovale closure using the Occlutech Figulla device: More than 1,300 patient-years of follow up.

Snijder RJR, Renes LE, Suttorp MJ, Ten Berg JM, Post MC.

Catheter Cardiovasc Interv. 2019 May 1;93(6):1080-1084. doi: 10.1002/ccd.27984. Epub 2018 Nov 20.

PMID:
30461175
6.

RV adaptation to increased afterload in congenital heart disease and pulmonary hypertension.

Driessen MMP, Leiner T, Sieswerda GT, van Dijk APJ, Post MC, Friedberg MK, Mertens L, Doevendans PA, Snijder RJ, Hulzebos EH, Meijboom FJ.

PLoS One. 2018 Oct 24;13(10):e0205196. doi: 10.1371/journal.pone.0205196. eCollection 2018.

7.

Pulmonary Arterial Hypertension and Hereditary Haemorrhagic Telangiectasia.

Vorselaars VMM, Hosman AE, Westermann CJJ, Snijder RJ, Mager JJ, Goumans MJ, Post MC.

Int J Mol Sci. 2018 Oct 17;19(10). pii: E3203. doi: 10.3390/ijms19103203. Review.

8.

Reproducibility of right-to-left shunt quantification using transthoracic contrast echocardiography in hereditary haemorrhagic telangiectasia.

Vorselaars VMM, Velthuis S, Huitema MP, Hosman AE, Westermann CJJ, Snijder RJ, Mager JJ, Post MC.

Neth Heart J. 2018 Apr;26(4):203-209. doi: 10.1007/s12471-018-1094-4.

9.

Systematic screening in hereditary hemorrhagic telangiectasia: a review.

Kroon S, Snijder RJ, Faughnan ME, Mager HJ.

Curr Opin Pulm Med. 2018 May;24(3):260-268. doi: 10.1097/MCP.0000000000000472. Review.

PMID:
29470256
10.

Tricuspid flow and regurgitation in congenital heart disease and pulmonary hypertension: comparison of 4D flow cardiovascular magnetic resonance and echocardiography.

Driessen MMP, Schings MA, Sieswerda GT, Doevendans PA, Hulzebos EH, Post MC, Snijder RJ, Westenberg JJM, van Dijk APJ, Meijboom FJ, Leiner T.

J Cardiovasc Magn Reson. 2018 Jan 15;20(1):5. doi: 10.1186/s12968-017-0426-7.

11.

Percutaneous closure of a patent foramen ovale after cryptogenic stroke.

Snijder RJR, Suttorp MJ, Ten Berg JM, Post MC.

Neth Heart J. 2018 Jan;26(1):5-12. doi: 10.1007/s12471-017-1063-3. Review.

12.

SMAD4 gene mutation increases the risk of aortic dilation in patients with hereditary haemorrhagic telangiectasia.

Vorselaars VMM, Diederik A, Prabhudesai V, Velthuis S, Vos JA, Snijder RJ, Westermann CJJ, Mulder BJ, Ploos van Amstel JK, Mager JJ, Faughnan ME, Post MC.

Int J Cardiol. 2017 Oct 15;245:114-118. doi: 10.1016/j.ijcard.2017.06.059.

PMID:
28874282
13.

Screening children for pulmonary arteriovenous malformations: Evaluation of 18 years of experience.

Hosman AE, de Gussem EM, Balemans WAF, Gauthier A, Westermann CJJ, Snijder RJ, Post MC, Mager JJ.

Pediatr Pulmonol. 2017 Sep;52(9):1206-1211. doi: 10.1002/ppul.23704. Epub 2017 Apr 13.

PMID:
28407366
14.

Pulmonary artery aneurysms and thrombi.

Steendam CMJ, Diederik AL, Dendooven A, Snijder RJ, Herder GJ.

Thorax. 2017 Dec;72(12):1167-1168. doi: 10.1136/thoraxjnl-2016-209752. Epub 2017 Feb 7. No abstract available.

PMID:
28174341
15.

Patent Foramen Ovale With Atrial Septal Aneurysm Is Strongly Associated With Migraine With Aura: A Large Observational Study.

Snijder RJ, Luermans JG, de Heij AH, Thijs V, Schonewille WJ, Van De Bruaene A, Swaans MJ, Budts WI, Post MC.

J Am Heart Assoc. 2016 Dec 1;5(12). pii: e003771.

16.

Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study.

Vinik AI, Perrot S, Vinik EJ, Pazdera L, Jacobs H, Stoker M, Long SK, Snijder RJ, van der Stoep M, Ortega E, Katz N.

BMC Neurol. 2016 Dec 6;16(1):251.

17.

Capsaicin 8% Patch in Painful Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study.

Simpson DM, Robinson-Papp J, Van J, Stoker M, Jacobs H, Snijder RJ, Schregardus DS, Long SK, Lambourg B, Katz N.

J Pain. 2017 Jan;18(1):42-53. doi: 10.1016/j.jpain.2016.09.008. Epub 2016 Oct 13.

18.

A novel standard to evaluate the impact of therapeutic agents on patient safety - The BURDEN OF THERAPY™©∗.

Abdulahad AK, Snijder RJ, Panni MK, Riaz FK, Karas AJ.

Contemp Clin Trials Commun. 2016 Sep 23;4:186-191. doi: 10.1016/j.conctc.2016.09.003. eCollection 2016 Dec 15.

19.

Microprobe transoesophageal echocardiographic guidance during transcatheter interatrial septal device implantation in heart failure with a preserved ejection fraction.

Snijder RJ, Swaans MJ, van der Heyden JA, Post MC.

EuroIntervention. 2016 Jun 20;12(3):401. doi: 10.4244/EIJV12I3A65. No abstract available.

20.

Life expextancy of parents with Hereditary Haemorrhagic Telangiectasia.

de Gussem EM, Edwards CP, Hosman AE, Westermann CJ, Snijder RJ, Faughnan ME, Mager JJ.

Orphanet J Rare Dis. 2016 Apr 22;11:46. doi: 10.1186/s13023-016-0427-x.

21.

Follow-up of pulmonary right-to-left shunt in hereditary haemorrhagic telangiectasia.

Vorselaars VM, Velthuis S, Snijder RJ, Westermann CJ, Vos JA, Mager JJ, Post MC.

Eur Respir J. 2016 Jun;47(6):1750-7. doi: 10.1183/13993003.01588-2015. Epub 2016 Mar 10.

22.

Interaction Between ALK1 Signaling and Connexin40 in the Development of Arteriovenous Malformations.

Gkatzis K, Thalgott J, Dos-Santos-Luis D, Martin S, Lamandé N, Carette MF, Disch F, Snijder RJ, Westermann CJ, Mager JJ, Oh SP, Miquerol L, Arthur HM, Mummery CL, Lebrin F.

Arterioscler Thromb Vasc Biol. 2016 Apr;36(4):707-17. doi: 10.1161/ATVBAHA.115.306719. Epub 2016 Jan 28.

PMID:
26821948
23.

Thoracic aorta dilation in patients with hereditary hemorrhagic telangiectasia due to SMAD4 gene mutation.

Vorselaars VM, Velthuis S, Snijder RJ, Mager JJ, Post MC.

Am J Med Genet A. 2016 Mar;170(3):811-2. doi: 10.1002/ajmg.a.37465. Epub 2015 Nov 14. No abstract available.

PMID:
26566607
24.

Pulmonary artery diameter to predict pulmonary hypertension in pulmonary sarcoidosis.

Huitema MP, Spee M, Vorselaars VM, Boerman S, Snijder RJ, van Es HW, Reesink HJ, Grutters JC, Post MC.

Eur Respir J. 2016 Feb;47(2):673-6. doi: 10.1183/13993003.01319-2015. Epub 2015 Oct 22. No abstract available.

25.

Pulmonary hypertension in hereditary haemorrhagic telangiectasia.

Vorselaars VM, Velthuis S, Snijder RJ, Vos JA, Mager JJ, Post MC.

World J Cardiol. 2015 May 26;7(5):230-7. doi: 10.4330/wjc.v7.i5.230.

26.

Reply to comments and questions of Dr. Correale et al. about our review concerning CTEPH.

Schölzel BE, Snijder RJ, Mager JJ, van Es HW, Plokker HW, Reesink HJ, Morshuis WJ, Post MC.

Neth Heart J. 2015 Mar;23(3):194-5. doi: 10.1007/s12471-015-0668-7. No abstract available.

27.

Percutaneous closure of secundum type atrial septal defects: More than 5-year follow-up.

Snijder RJ, Suttorp MJ, Berg JM, Post MC.

World J Cardiol. 2015 Mar 26;7(3):150-6. doi: 10.4330/wjc.v7.i3.150.

28.

Percutaneous left atrial appendage closure-An alternative strategy for anticoagulation in atrial fibrillation and hereditary hemorrhagic telangiectasia?

Vorselaars VM, Velthuis S, Swaans MJ, Mager JJ, Snijder RJ, Rensing BJ, Boersma LV, Post MC.

Cardiovasc Diagn Ther. 2015 Feb;5(1):49-53. doi: 10.3978/j.issn.2223-3652.2015.01.02.

29.

Clinical implications of pulmonary shunting on saline contrast echocardiography.

Velthuis S, Buscarini E, Gossage JR, Snijder RJ, Mager JJ, Post MC.

J Am Soc Echocardiogr. 2015 Mar;28(3):255-63. doi: 10.1016/j.echo.2014.12.008. Epub 2015 Jan 23. Review.

PMID:
25623000
30.

Pulmonary shunt fraction measurement compared to contrast echocardiography in hereditary haemorrhagic telangiectasia patients: time to abandon the 100% oxygen method?

Velthuis S, Vorselaars VM, Westermann CJ, Snijder RJ, Mager JJ, Post MC.

Respiration. 2015;89(2):112-8. doi: 10.1159/000368416. Epub 2015 Jan 21.

31.

Chronic thromboembolic pulmonary hypertension.

Schölzel BE, Snijder RJ, Mager JJ, van Es HW, Plokker HW, Reesink HJ, Morshuis WJ, Post MC.

Neth Heart J. 2014 Dec;22(12):533-41. doi: 10.1007/s12471-014-0592-2.

32.

Direct haemodynamic effects of pulmonary arteriovenous malformation embolisation.

Vorselaars VM, Velthuis S, Mager JJ, Snijder RJ, Bos WJ, Vos JA, van Strijen MJ, Post MC.

Neth Heart J. 2014 Aug;22(7-8):328-33. doi: 10.1007/s12471-014-0539-7.

33.

Predicting the size of pulmonary arteriovenous malformations on chest computed tomography: a role for transthoracic contrast echocardiography.

Velthuis S, Buscarini E, Mager JJ, Vorselaars VM, van Gent MW, Gazzaniga P, Manfredi G, Danesino C, Diederik AL, Vos JA, Gandolfi S, Snijder RJ, Westermann CJ, Post MC.

Eur Respir J. 2014 Jul;44(1):150-9. doi: 10.1183/09031936.00133713. Epub 2014 Mar 6.

34.

Prediction of outcome after PEA in chronic thromboembolic pulmonary hypertension using indexed pulmonary artery diameter.

Schölzel BE, Post MC, Dymarkowski S, Wuyts W, Meyns B, Budts W, Morshuis W, Snijder RJ, Delcroix M.

Eur Respir J. 2014 Mar;43(3):909-12. doi: 10.1183/09031936.00174113. No abstract available.

35.

Percutaneous reclosure of a patent foramen ovale after bioabsorbable device implantation.

Snijder RJ, Post MC, Suttorp MJ.

EuroIntervention. 2014 Nov;10(7):860. doi: 10.4244/EIJV10I7A146. No abstract available.

36.

Persistent high residual shunt rate 2 years after patent foramen ovale closure using a bioabsorbable device.

Snijder RJ, Post MC, Mulder TB, Van den Branden BJ, Ten Berg JM, Suttorp MJ.

JACC Cardiovasc Interv. 2014 Jan;7(1):106-7. doi: 10.1016/j.jcin.2013.05.026. No abstract available.

37.

Pressure overloaded right ventricles: a multicenter study on the importance of trabeculae in RV function measured by CMR.

Driessen MM, Baggen VJ, Freling HG, Pieper PG, van Dijk AP, Doevendans PA, Snijder RJ, Post MC, Meijboom FJ, Sieswerda GT, Leiner T, Willems TP.

Int J Cardiovasc Imaging. 2014 Mar;30(3):599-608. doi: 10.1007/s10554-014-0367-2. Epub 2014 Jan 20.

PMID:
24442769
38.

Role of transthoracic contrast echocardiography in the clinical diagnosis of hereditary hemorrhagic telangiectasia.

Velthuis S, Vorselaars VMM, van Gent MWF, Westermann CJJ, Snijder RJ, Mager JJ, Post MC.

Chest. 2013 Dec;144(6):1876-1882. doi: 10.1378/chest.13-0716.

PMID:
23907523
39.

Grade of pulmonary right-to-left shunt on contrast echocardiography and cerebral complications: a striking association.

Velthuis S, Buscarini E, van Gent MWF, Gazzaniga P, Manfredi G, Danesino C, Schonewille WJ, Westermann CJJ, Snijder RJ, Mager JJ, Post MC.

Chest. 2013 Aug;144(2):542-548. doi: 10.1378/chest.12-1599.

PMID:
23429940
40.

Hereditary hemorrhagic telangiectasia: how accurate are the clinical criteria?

van Gent MW, Velthuis S, Post MC, Snijder RJ, Westermann CJ, Letteboer TG, Mager JJ.

Am J Med Genet A. 2013 Mar;161A(3):461-6. doi: 10.1002/ajmg.a.35715. Epub 2013 Feb 8.

PMID:
23401183
41.

Pulmonary artery embolization for refractory hypoxemia caused by invasive mucinous adenocarcinoma.

Trietsch F, Snijder RJ, Kloosterziel C, van den Heuvel DA.

J Thorac Oncol. 2013 Feb;8(2):e15-6. doi: 10.1097/JTO.0b013e31827a88f3. No abstract available.

42.

Imaging of an unusual case of a completely unroofed coronary sinus without persistent left superior vena cava.

Snijder RJ, Schaap J, Verzijlbergen JF, Post MC.

Eur Heart J Cardiovasc Imaging. 2013 Mar;14(3):297. doi: 10.1093/ehjci/jes190. Epub 2012 Sep 21. No abstract available.

PMID:
23002197
43.

Increased number of pulmonary embolisms in sarcoidosis patients.

Vorselaars ADM, Snijder RJ, Grutters JC.

Chest. 2012 Mar;141(3):826-827. doi: 10.1378/chest.11-2514. No abstract available.

PMID:
22396572
44.

Combined use of exercise electrocardiography, coronary calcium score and cardiac CT angiography for the prediction of major cardiovascular events in patients presenting with stable chest pain.

Versteylen MO, Joosen IA, Winkens MH, Laufer EM, Snijder RJ, Wildberger JE, Crijns HJ, Narula J, Hofstra L.

Int J Cardiol. 2013 Jul 15;167(1):121-5. doi: 10.1016/j.ijcard.2011.12.016. Epub 2012 Jan 5.

PMID:
22225760
45.

Clinical worsening during long-term follow-up in inoperable chronic thromboembolic pulmonary hypertension.

Scholzel BE, Post MC, Thijs Plokker HW, Snijder RJ.

Lung. 2012 Apr;190(2):161-7. doi: 10.1007/s00408-011-9350-z. Epub 2011 Dec 8.

PMID:
22160210
46.

CT evaluation of chronic thromboembolic pulmonary hypertension.

Willemink MJ, van Es HW, Koobs L, Morshuis WJ, Snijder RJ, van Heesewijk JP.

Clin Radiol. 2012 Mar;67(3):277-85. doi: 10.1016/j.crad.2011.09.012. Epub 2011 Nov 25. Review.

PMID:
22119298
47.

WITHDRAWN: Predictors of long-term survival in pulmonary hypertension treated with bosentan.

Bresser P, Vis JC, Berger RM, Vliegen HW, Vonk MC, Snijder RJ, van den Toorn LM, van Dijk AP, Boomars KA, van Daal GJ, Mulder BJ.

J Heart Lung Transplant. 2011 Mar 17. [Epub ahead of print]

PMID:
21414807
48.

Relation between migraine and size of echocardiographic intrapulmonary right-to-left shunt.

van Gent MW, Mager JJ, Snijder RJ, Westermann CJ, Plokker HW, Schonewille WJ, Thijs V, Post MC.

Am J Cardiol. 2011 May 1;107(9):1399-404. doi: 10.1016/j.amjcard.2010.12.052. Epub 2011 Mar 2.

PMID:
21371682
49.

Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia.

Lebrin F, Srun S, Raymond K, Martin S, van den Brink S, Freitas C, Bréant C, Mathivet T, Larrivée B, Thomas JL, Arthur HM, Westermann CJ, Disch F, Mager JJ, Snijder RJ, Eichmann A, Mummery CL.

Nat Med. 2010 Apr;16(4):420-8. doi: 10.1038/nm.2131. Epub 2010 Apr 4.

PMID:
20364125
50.

Out of hospital treatment of acute pulmonary embolism in patients with a low NT-proBNP level.

Agterof MJ, Schutgens RE, Snijder RJ, Epping G, Peltenburg HG, Posthuma EF, Hardeman JA, van der Griend R, Koster T, Prins MH, Biesma DH.

J Thromb Haemost. 2010 Jun;8(6):1235-41. doi: 10.1111/j.1538-7836.2010.03831.x. Epub 2010 Mar 3.

Supplemental Content

Loading ...
Support Center